Companies: 10,795·Total market cap: $144.5T
Immage Biotherapeutics Corp.

Immage Biotherapeutics Corp.

IMMGOTCFinancial Services● Active
$0.00
+$0.00(+0.00%)
Market Cap$15174
P/E Ratio
52W High$0.0001
52W Low$0.000001

Immage Biotherapeutics Corp. (IMMG) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

immg · pe ratio · data through Aug 31, 2016

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Immage Biotherapeutics Corp. (IMMG) measures how much investors pay for each dollar of the company's trailing earnings. IMMG's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2016-08-31

Forward P/E
N/A
EPS (TTM)
-$0.00
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Immage Biotherapeutics Corp. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2012 – 2016 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Financial - Conglomerates · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Immage Biotherapeutics Corp.
Immage Biotherapeutics Corp.You
IMMG
$0MN/A-$0.00
Axis Technologies Group, Inc.
Axis Technologies Group, Inc.
AXTG
$0MN/A-$0.00
First Bitcoin Capital Corp.
First Bitcoin Capital Corp.
BITCF
$0MN/A-$1.30
BLOK Technologies Inc.
BLOK Technologies Inc.
BLPFF
$0MN/A-$0.07
China Finance, Inc.
China Finance, Inc.
CHFI
$0M13.38x$0.07
CTR Investments & Consulting, Inc.
CTR Investments & Consulting, Inc.
CIVX
$0MN/A-$0.00
AgriEuro Corp.
AgriEuro Corp.
EURI
$0MN/A-$0.00

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2016-08-31Latest
FY2016
$-0.00
2015-08-31
FY2015
$-0.00
2014-09-30
FY2014
$-0.03
2013-09-30
FY2013
$-0.01
2012-09-30
FY2012
$-0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Immage Biotherapeutics Corp. (IMMG) measures how much investors pay for each dollar of the company's trailing earnings. IMMG's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.00 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

IMMG pe ratio · 6 questions

IMMG's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of -$0.00. Data sourced from Financial Modeling Prep via IMMG's SEC 10-K and 10-Q filings.

IMMG PE ratioWhat is IMMG PE ratioCurrent PE ratio of IMMGIMMG PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Immage Biotherapeutics Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08